Blue Edge Capital »

SPDR S&P Biotech shares owned by Blue Edge Capital

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Blue Edge Capital from 13F filings

Historical chart of Blue Edge Capital investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Blue Edge Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Blue Edge Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $499k 5.4k 92.71
2024-03-31 $510k 5.4k 94.89

More positions owned by Blue Edge Capital

Vanguard Growth ETF (VUG)
Vanguard Value ETF (VTV)
Vanguard Mega Cap 300 Growth Index ETF (MGK)
iShares S&P 500 Growth Index (IVW)
Ishares Tr core msci euro (IEUR)
Spdr S&p 500 Etf (SPY)
iShares Lehman 7-10 Yr Treas. Bond (IEF)
Vanguard Mega Cap 300 Value Index ETF (MGV)
Vanguard Short Term Corporate Bond ETF (VCSH)
iShares S&P MidCap 400 Growth (IJK)
iShares Lehman 3-7 Yr Treasury Bond (IEI)
iShares S&P MidCap 400 Value Index (IJJ)
Apple (AAPL)
Ishares Tr etf msci usa (ESGU)
Vanguard Pacific ETF (VPL)

View all positions for Blue Edge Capital

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Citadel Advisors
Morgan Stanley
Susquehanna International
NWI Management
Bnp Paribas Arbitrage, Snc
Twin Tree Management
Parallax Volatility Advisers
Wells Fargo & Company
Logos Global Management

View all funds holding SPDR S&P Biotech